P2P Awards are offered by the BC SUPPORT Unit in partnership with the Michael Smith Foundation for Health Research (MSFHR). These awards help BC-based patient-oriented research teams pilot and test the feasibility of their research project, to make their future grant applications stronger.
We strongly urge you to review the section on Pilot/Feasibility studies prior to submission and contact us if you have any questions.
Through P2P Awards, we hope to build and strengthen capacity in patient-oriented research in BC.
We acknowledge the Michael Smith Foundation for Health Research as a funder of the BC SUPPORT Unit and the P2P awards. Award and payment administrative support is also provided by MSFHR.
The P2P awards are intended to support pilot/feasibility studies which we define below (from: NIHR (2017) RfPB Guidance on Applying for Feasibility Studies).
Pilot studies are a version of the main (future) study that is run in miniature to test whether the components of the main study can work together. It is focused on ensuring that the processes of the main study (e.g. recruitment, randomisation, treatment, and follow-up assessments) all run smoothly. It will therefore resemble the main study in many respects, including an assessment of the primary outcome. In some cases, this will be the first phase of the main study, and data from the pilot phase may contribute to the final analysis; this can be referred to as an internal pilot. Conversely, if at the end of the pilot study, the data are analysed and set aside, this is considered an external pilot.
Feasibility studies are pieces of research done before a main study in order to answer the question “Can this study be done?” They are used to estimate important parameters that are needed to design the main study. The design of a feasibility study generally involves listing those parameters which are uncertain and describing the methods for improving their precision so that the main study will have a better chance of success. Feasibility studies do not evaluate the outcome of interest; that is left to the main (future) study.
From the definitions it should be clear that eligible P2P projects:
- Must have a well-defined research question, and are research projects;
- Must yield findings that allow the co-leads to apply for future funding for the main study;
- Must not be a pilot program or service
Although pilot projects may be important they are unfortunately not in scope for this funding opportunity.
For further information about pilot and feasibility studies, please refer to the following examples in the literature:
Leon AC, Davis LL, and Kraemer HC. The Role and Interpretation of Pilot Studies in Clinical Research. J. Psychiatr Res. (2011) 45(5): 626-929. Last accessed: July 16, 2019.
Lancaster GA. Pilot and feasibility studies come of age! Pilot and Feasibility Studies. (2015) 1:1. Last accessed: July 16, 2019.
Abbott JH. The Distinction Between Randomized Clinical trials (RCTs) and Preliminary Feasibility and Pilot Studies: What They Are and Are Not. J Orthop Sports Phys Ther. (2014) 44 (8): 555-558. Last accessed: July 16, 2019.
Bowen JB, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner, D et al. How We Design Feasibility Studies. Am J Prev Med (2009) 36(5): 452-457. Last accessed: July 16, 2019.
Moore CG, Carter RE, Nietert PJ, and Stewart PW. Recommendations for Planning Pilot Studies in Clinical and Translational Research. Clin Transl Sci (2011) 4(5): 332-337. Last accessed: July 16, 2019.
If you’re not sure whether your proposed research is a pilot/feasibility study, please get in touch.
Unlike previous competitions, the 2019-20 P2P competition is a two-stage application process - the first of which is the Letter of Intent (LOI) phase.
Interested teams must complete the LOI form and be prepared to provide the following information:
- Name and contact details of the research co-lead;
- A patient co-lead does not have to be identified for the LOI phase but must be named on the grant submission
- The title of the proposed project;
- The research question to be explored;
- A description of how patient partners will be engaged in the research; and
- Plans for the research project after completion of the pilot/feasibility study.
LOI submissions will be received from 9:00am on August 12, 2019 until 11:59pm PST on September 13, 2019. Any submissions received after that will be deemed ineligible.
IMPORTANT INFO: if you have already submitted your application and want to make changes please contact us.
All eligible LOI submissions will be screened by the SUPPORT Unit to ensure they meet award eligibility criteria. There will be no judgment of assessment of the quality of the application at this stage.
LOI submissions meeting the award eligibility criteria will be invited to submit a full application.
All LOI submissions will be notified of their status by September 18, 2019.
- Name and contact details of the research co-lead;
Information for the full application can be found here:
Application submissions open on September 19th, 2019 on MSFHR's ApplyNet, and close on October 31st, 2019.
- 2020 P2P Instructions – this document provides a step-by-step guide for applicants while completing the P2P application on our system.
- Researcher Co-Lead Full Application (P2P): Researcher Co-Lead sample PDF
Access MSFHR's ApplyNet.
Documents for the 2019/20 competition are available here:
To begin your application: